Pomalidomide (POM)+ low-dose dexamethasone (LoDEX) safety and efficacy in patients (pts) with relapsed and/or refractory multiple myeloma (RRMM) previously treated with a …
user-5f8411ab4c775e9685ff56d3（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要